Yangwei Fan

415 total citations
20 papers, 278 citations indexed

About

Yangwei Fan is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yangwei Fan has authored 20 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yangwei Fan's work include Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Yangwei Fan is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Yangwei Fan collaborates with scholars based in China. Yangwei Fan's co-authors include Enxiao Li, Ke Ma, Yuan Hu, Chuying Wang, Yinying Wu, Danfeng Dong, Jing Ning, Yu Shi, Qianqian Geng and Xin Wei and has published in prestigious journals such as Journal of Clinical Oncology, Medicine and Oncotarget.

In The Last Decade

Yangwei Fan

19 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangwei Fan China 10 147 137 73 56 36 20 278
Rahul Sreekumar United Kingdom 7 199 1.4× 110 0.8× 123 1.7× 37 0.7× 33 0.9× 12 317
Atsutaka Masuda Japan 9 142 1.0× 85 0.6× 92 1.3× 32 0.6× 51 1.4× 19 279
Manjusha Thakar United States 9 204 1.4× 98 0.7× 81 1.1× 27 0.5× 64 1.8× 10 348
Shaowei Song China 10 147 1.0× 149 1.1× 101 1.4× 44 0.8× 37 1.0× 21 315
Chengcheng Shi China 8 168 1.1× 93 0.7× 56 0.8× 24 0.4× 75 2.1× 22 261
María Rodríguez‐Remírez Spain 11 139 0.9× 116 0.8× 72 1.0× 18 0.3× 36 1.0× 19 280
D. Peereboom United States 7 134 0.9× 136 1.0× 41 0.6× 53 0.9× 95 2.6× 20 317
Chuanqiang Wu China 7 174 1.2× 97 0.7× 104 1.4× 38 0.7× 27 0.8× 16 268
Ilaria Passacantilli Italy 7 381 2.6× 87 0.6× 172 2.4× 37 0.7× 30 0.8× 7 460
Katja Helenius Finland 5 276 1.9× 119 0.9× 89 1.2× 21 0.4× 48 1.3× 6 383

Countries citing papers authored by Yangwei Fan

Since Specialization
Citations

This map shows the geographic impact of Yangwei Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangwei Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangwei Fan more than expected).

Fields of papers citing papers by Yangwei Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangwei Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangwei Fan. The network helps show where Yangwei Fan may publish in the future.

Co-authorship network of co-authors of Yangwei Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Yangwei Fan. A scholar is included among the top collaborators of Yangwei Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangwei Fan. Yangwei Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yinying, Yangwei Fan, Yu Shi, et al.. (2025). A multi-omics prognostic model of cuproptosis affects the prognosis of stomach adenocarcinoma. Clinical Epigenetics. 17(1). 99–99. 1 indexed citations
3.
4.
Wu, Yinying, et al.. (2024). Tislelizumab with anlotinib and chemotherapy for second-line treatment of pancreatic ductal adenocarcinoma: A pilot study early result.. Journal of Clinical Oncology. 42(16_suppl). e16316–e16316. 1 indexed citations
5.
Shi, Yu, Liankang Sun, Rui Zhang, et al.. (2021). Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells. Journal of Experimental & Clinical Cancer Research. 40(1). 14–14. 42 indexed citations
6.
Hu, Yuan, Yu Shi, Danfeng Dong, et al.. (2021). Apatinib inhibits pancreatic cancer growth, migration and invasion through the PI3K/AKT and ERK1/2/MAPK pathways. Translational Cancer Research. 10(7). 3306–3316. 9 indexed citations
7.
Hu, Yuan, et al.. (2021). Inhibition of Ras protein activator like 2 produces antitumor effects in gastric cancer via the suppression of YAP1 activation. Environmental Toxicology. 37(3). 527–538. 3 indexed citations
8.
Wu, Yinying, et al.. (2020). Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: an adjusted indirect meta-analysis and systematic review. Therapeutic Advances in Medical Oncology. 12. 3863555972–3863555972. 7 indexed citations
9.
Wu, Yinying, et al.. (2020). Efficacy and safety of regorafenib as third-line therapy in metastatic colorectal cancer: An indirect meta-analysis.. Journal of Clinical Oncology. 38(4_suppl). 119–119. 1 indexed citations
11.
Shi, Yu, Yangwei Fan, Yuan Hu, et al.. (2019). α‐Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades. Journal of Cellular and Molecular Medicine. 24(1). 760–771. 19 indexed citations
12.
Wang, Chuying, Jiao Yu, Yangwei Fan, et al.. (2019). The Clinical Significance of PD-L1/PD-1 Expression in Gastroenteropancreatic Neuroendocrine Neoplasia.. PubMed. 49(4). 448–456. 16 indexed citations
13.
Ma, Ke, Yangwei Fan, & Yuan Hu. (2018). Prognostic and clinical significance of metastasis-associated gene 1 overexpression in solid cancers. Medicine. 97(41). e12292–e12292. 1 indexed citations
15.
Ma, Ke, Yangwei Fan, Xin Wei, et al.. (2017). MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer. Oncotarget. 8(24). 38825–38840. 24 indexed citations
16.
Zou, Long, et al.. (2017). Molecular classification of esophagogastric junction carcinoma correlated with prognosis. OncoTargets and Therapy. Volume 10. 4765–4772. 5 indexed citations
17.
Yang, Haixia, Jun Liang, Ke Ma, et al.. (2016). Knockdown of RHOC by shRNA suppresses invasion and migration of cholangiocellular carcinoma cells via inhibition of MMP2, MMP3, MMP9 and epithelial-mesenchymal transition. Molecular Medicine Reports. 13(6). 5255–5261. 24 indexed citations
18.
Fan, Yangwei, Ke Ma, Chuying Wang, et al.. (2016). Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors. OncoTargets and Therapy. Volume 9. 6075–6082. 45 indexed citations
19.
Ma, Ke, Chuying Wang, Qianqian Geng, et al.. (2016). Recombinant adeno-associated virus-delivered anginex inhibits angiogenesis and growth of HUVECs by regulating the Akt, JNK and NF-κB signaling pathways. Oncology Reports. 35(6). 3505–3513. 3 indexed citations
20.
Yang, Haixia, Ke Ma, Yangwei Fan, et al.. (2015). HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma. Oncology Reports. 34(4). 1681–1691. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026